Kymera Investor Day Presentation Deck slide image

Kymera Investor Day Presentation Deck

STAT3 Degraders in Immune-Inflammation and Fibrosis Ashwin Gollerkeri, M.D., SVP, Head of Development, Kymera KYMERA KYMERA R&D DAY - December 16th, 2021 5 KYMERA EST. 2016
View entire presentation